-
1.
公开(公告)号:US11325907B2
公开(公告)日:2022-05-10
申请号:US16965377
申请日:2019-01-29
IPC分类号: C07D471/04 , A61P19/02
摘要: Disclosed are a crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and a preparation process therefor, and use of the crystal form in the manufacture of a medicament for treating a disease associated with PDE4 receptor.
-
公开(公告)号:US11319330B2
公开(公告)日:2022-05-03
申请号:US17274236
申请日:2019-09-09
发明人: Maoyi Lei , Yunfu Luo , Yu Xu , Guoli Zhang , Jinghong Dong , Jian Li , Shuhui Chen
IPC分类号: C07D405/04 , C07D405/12 , C07D513/04 , C07D491/048 , C07D498/04 , A61P35/00
摘要: Disclosed are a series of tricyclic furan-substituted piperidinedione compounds and an application thereof in preparing a drug for treating a disease related to CRBN protein. In particular, disclosed is a derivative compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US11136315B2
公开(公告)日:2021-10-05
申请号:US16960468
申请日:2019-01-11
发明人: Bin Chen , Xiawei Wei , Xuefeng Sun , Lei Zhang , Zhaoying Xu , Wenli Li , Peng Zhang , Feng Gao , Yunfu Luo , Jian Li , Shuhui Chen
IPC分类号: C07D405/12 , A61P11/00 , C07D211/54 , C07D215/38 , C07D277/64 , C07D307/81 , C07D333/52 , C07D409/12 , C07D413/12 , C07D417/12 , C07D491/048
摘要: A compound as a CXCR2 antagonist and an application thereof in preparing a drug as a CXCR2 antagonist. In particular, the present invention relates to a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof.
-
公开(公告)号:US10532986B2
公开(公告)日:2020-01-14
申请号:US16325626
申请日:2017-08-22
发明人: Yunfu Luo , Chundao Yang , Maoyi Lei , Lanbao Sun , Guoping Hu , Jian Li , Shuhui Chen
IPC分类号: C07D235/26 , C07D263/58 , C07D401/04 , C07D403/04 , C07D403/06 , C07D405/04 , C07D409/04 , C07D417/04 , A61P29/00 , A61K31/423 , A61P37/00 , A61K31/4184 , C07D401/10 , C07D403/10 , C07D405/10 , C07D409/10 , C07D417/10
摘要: Provided are a phosphodiesterase-4 (PDE4) inhibitor and application thereof in preparation of a medication for treating a disease related to PDE4. Specifically disclosed is a compound as shown in formula (I) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20220119376A1
公开(公告)日:2022-04-21
申请号:US17273997
申请日:2019-09-09
发明人: Maoyi Lei , Yunfu Luo , Yu Xu , Guoli Zhang , Zhijuan Yu , Jian Li , Shuhui Chen
IPC分类号: C07D413/14 , C07D498/04 , C07D413/04 , A61P35/00
摘要: The present invention discloses a series of tricyclic compounds and use thereof in preparing a medicament for treating a disease related to CRBN protein. Specifically, the present invention discloses a derivative compound of formula (I) or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US11155523B2
公开(公告)日:2021-10-26
申请号:US16468127
申请日:2017-12-11
发明人: Yunfu Luo , Yuyong Ba , Shuhui Chen
IPC分类号: C07D233/64 , C07D213/34 , C07D213/56 , C07D249/08 , C07D233/58
摘要: Provided is a CCR2/CCR5 receptor antagonist and the use thereof in the preparation of a drug for treating diseases associated with the CCR2/CCR5. In particular, disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20240317722A1
公开(公告)日:2024-09-26
申请号:US18580401
申请日:2022-07-12
发明人: Maoyi Lei , Yu Xu , Yunfu Luo , Shuhui Chen
IPC分类号: C07D405/04 , A61K31/4525
CPC分类号: C07D405/04 , A61K31/4525
摘要: A heteroaryl-3-piperidinedione compound and the use thereof. Particularly disclosed are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US11905276B2
公开(公告)日:2024-02-20
申请号:US17642064
申请日:2020-09-14
发明人: Yunfu Luo , Maoyi Lei , Yu Xu , Junmiao Li , Guoli Zhang , Jinghong Dong , Shuhui Chen
IPC分类号: C07D405/04 , C07D405/14 , C07D491/107 , C07D409/04 , C07D491/048 , C07D487/08 , C07D487/04 , C07D495/04 , C07D498/04 , C07D413/04
CPC分类号: C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D487/04 , C07D487/08 , C07D491/048 , C07D491/107 , C07D495/04 , C07D498/04
摘要: A compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and disclosed is an application thereof in the preparation of a medication for treating diseases related to a CRBN receptor.
-
-
-
-
-
-
-